logo

For the Inventor, By the Inventor

Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 18

% Expired Patents = 38.9



Trademarks = 3

Forward Citations = 97

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Minsheng He (12 out of 29 patents)

silverMedal Xiao-Yi Xiao (12 out of 35 patents)

bronzeMedal Roger B Clark (11 out of 22 patents)

4.  Louis Plamondon (9 out of 28 patents)

5.  Magnus Ronn (7 out of 11 patents)

6.  Diana Katharine Hunt (7 out of 7 patents)

7.  Cuixiang Sun (6 out of 7 patents)

8.  Wu-Yan Zhang (6 out of 6 patents)

9.  Danny LaFrance (5 out of 5 patents)

10.  Chi-Li Chen (5 out of 9 patents)

11.  Jingye Zhou (4 out of 17 patents)

12.  Magnus Rönn (4 out of 4 patents)

13.  Robert Zahler (3 out of 74 patents)

14.  Philip C Hogan (3 out of 3 patents)

15.  Yansheng Liu (3 out of 3 patents)


18 patents:

1. 12570604 - Polymorphic forms of a tetracycline compound and uses thereof (2026-03-10),
2. 12269807 - Crystalline forms of eravacycline (2025-04-08),
3. 11578044 - Crystalline forms of eravacycline (2023-02-14),
4. 10961190 - Crystalline forms of eravacycline (2021-03-30),
5. 10913712 - Tetracycline compounds (2021-02-09),
6. 10618879 - Semi-synthesis procedures (2020-04-14),
7. 10315992 - Tetracyline compounds (2019-06-11),
8. 10087157 - Semi-synthesis procedures (2018-10-02),
9. 10072007 - Tetracycline compounds (2018-09-11),
10. 9624166 - Tetracycline compounds (2017-04-18),
11. 9573895 - Tetracycline compounds (2017-02-21),
12. 9371283 - Polycyclic tetracycline compounds (2016-06-21),
13. 9315451 - Tetracycline compounds (2016-04-19),
14. 8906887 - C7-fluoro substituted tetracycline compounds (2014-12-09),
15. 8828988 - 8-AZA tetracycline compounds (2014-09-09),
Company Overview
Tetraphase Pharmaceuticals, Inc. is a biopharmaceutical company based in Watertown, MA, focused on developing innovative antibiotics to combat serious infections caused by multidrug-resistant bacteria. The company specializes in the discovery and development of novel therapies that address unmet medical needs in infectious diseases. With a commitment to advancing healthcare, Tetraphase leverages its proprietary technology platform to create effective treatments that aim to improve patient outcomes and enhance the quality of care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#24 in Watertown, MA

#1,102 in Massachusetts

#17,980 in US

#34,263 in the World

Watertown, MA (US)
Watertown, MA, United States of America

Tetraphase Pharmaceuticals, Inc.

Forward Citations = 97

19 inventors:

goldMedal Minsheng He (12 out of 29 patents)

silverMedal Xiao-Yi Xiao (12 out of 35 patents)

bronzeMedal Roger B Clark (11 out of 22 patents)

4.  Louis Plamondon (9 out of 28 patents)

5.  Magnus Ronn (7 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tetraphase Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/tetraphase-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…